1. Home
  2. LII vs NTRA Comparison

LII vs NTRA Comparison

Compare LII & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lennox International Inc.

LII

Lennox International Inc.

HOLD

Current Price

$511.08

Market Cap

17.4B

Sector

Industrials

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$244.06

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LII
NTRA
Founded
1895
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.4B
27.0B
IPO Year
1999
2015

Fundamental Metrics

Financial Performance
Metric
LII
NTRA
Price
$511.08
$244.06
Analyst Decision
Hold
Strong Buy
Analyst Count
12
16
Target Price
$605.18
$227.69
AVG Volume (30 Days)
451.7K
1.7M
Earning Date
10-22-2025
11-06-2025
Dividend Yield
1.02%
N/A
EPS Growth
12.46
N/A
EPS
23.67
N/A
Revenue
$5,345,300,000.00
$2,116,676,000.00
Revenue This Year
N/A
$32.77
Revenue Next Year
$7.34
$16.51
P/E Ratio
$21.62
N/A
Revenue Growth
3.77
38.17
52 Week Low
$443.19
$125.38
52 Week High
$689.44
$245.59

Technical Indicators

Market Signals
Indicator
LII
NTRA
Relative Strength Index (RSI) 60.54 80.03
Support Level $481.60 $233.67
Resistance Level $499.95 $240.18
Average True Range (ATR) 14.23 7.39
MACD 6.58 0.68
Stochastic Oscillator 99.78 97.49

Price Performance

Historical Comparison
LII
NTRA

About LII Lennox International Inc.

Lennox International manufactures and distributes heating, ventilating, air conditioning, and refrigeration products to replacement (75% of sales) and new construction (25% of sales) markets. In fiscal 2024, residential HVAC was 67% of sales and commercial HVAC and Heatcraft refrigeration was 33% of sales. The company goes to market with multiple brands, but Lennox is the company's flagship HVAC brand. The Texas-based company is focused on North America after the sale of its European HVAC and refrigeration businesses in late 2023.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: